155 related articles for article (PubMed ID: 20375200)
21. Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. Regulation by multiple mechanisms.
Ram PA; Waxman DJ
J Biol Chem; 1992 Feb; 267(5):3294-301. PubMed ID: 1737785
[TBL] [Abstract][Full Text] [Related]
22. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.
Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X
Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730
[TBL] [Abstract][Full Text] [Related]
23. Suppression of cytochrome p450 reductase enhances long-term hematopoietic stem cell repopulation efficiency in mice.
Zhang Y; Dong F; Zhang N; Cheng H; Pang Y; Wang X; Xu J; Ding X; Cheng T; Gu J; Yuan W
PLoS One; 2013; 8(7):e69913. PubMed ID: 23922855
[TBL] [Abstract][Full Text] [Related]
24. Neurobehavioral abnormalities in a brain-specific NADPH-cytochrome P450 reductase knockout mouse model.
Fang C; Bolivar VJ; Gu J; Yang W; Zeitlin SO; Ding X
Neuroscience; 2012 Aug; 218():170-80. PubMed ID: 22626646
[TBL] [Abstract][Full Text] [Related]
25. Effect of Cytochrome P450 Reductase Deficiency on 2-Amino-9H-pyrido[2,3-b]indole Metabolism and DNA Adduct Formation in Liver and Extrahepatic Tissues of Mice.
Turesky RJ; Konorev D; Fan X; Tang Y; Yao L; Ding X; Xie F; Zhu Y; Zhang QY
Chem Res Toxicol; 2015 Dec; 28(12):2400-10. PubMed ID: 26583703
[TBL] [Abstract][Full Text] [Related]
26. The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5.
Xie F; Zhou X; Genter MB; Behr M; Gu J; Ding X
Drug Metab Dispos; 2011 Jun; 39(6):947-51. PubMed ID: 21415250
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of NADPH-cytochrome P450 reductase by tannic acid in rat liver microsomes and primary hepatocytes: methodological artifacts and application to ischemia-reperfusion injury.
Pillai VC; Mehvar R
J Pharm Sci; 2011 Aug; 100(8):3495-3505. PubMed ID: 21387315
[TBL] [Abstract][Full Text] [Related]
28. Cloning and expression of koala (Phascolarctos cinereus) liver cytochrome P450 reductase.
Kong S; Ngo SN; McKinnon RA; Stupans I
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Jul; 150(1):1-9. PubMed ID: 19444989
[TBL] [Abstract][Full Text] [Related]
29. Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.
Porter TD; Banerjee S; Stolarczyk EI; Zou L
Drug Metab Dispos; 2011 Jun; 39(6):966-73. PubMed ID: 21368239
[TBL] [Abstract][Full Text] [Related]
30. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.
Wang XJ; Chamberlain M; Vassieva O; Henderson CJ; Wolf CR
Biochem J; 2005 Jun; 388(Pt 3):857-67. PubMed ID: 15717863
[TBL] [Abstract][Full Text] [Related]
31. Proximal Tubular Vacuolization and Hypersensitivity to Drug-Induced Nephrotoxicity in Male Mice With Decreased Expression of the NADPH-Cytochrome P450 Reductase.
Ding L; Li L; Liu S; Bao X; Dickman KG; Sell SS; Mei C; Zhang QY; Gu J; Ding X
Toxicol Sci; 2020 Feb; 173(2):362-372. PubMed ID: 31693140
[TBL] [Abstract][Full Text] [Related]
32. Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADH-b5 reductase in variability of CYP3A activity in human liver microsomes.
Gan L; von Moltke LL; Trepanier LA; Harmatz JS; Greenblatt DJ; Court MH
Drug Metab Dispos; 2009 Jan; 37(1):90-6. PubMed ID: 18838505
[TBL] [Abstract][Full Text] [Related]
33. Decrease in NADPH-cytochrome P450 reductase activity of the human heart, Liver and lungs in the presence of alpha-lipoic acid.
Dudka J
Ann Nutr Metab; 2006; 50(2):121-5. PubMed ID: 16391466
[TBL] [Abstract][Full Text] [Related]
34. The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism.
Mutch DM; Klocke B; Morrison P; Murray CA; Henderson CJ; Seifert M; Williamson G
J Proteome Res; 2007 Oct; 6(10):3976-84. PubMed ID: 17722906
[TBL] [Abstract][Full Text] [Related]
35. Impact of hepatic P450-mediated biotransformation on the disposition and respiratory tract toxicity of inhaled naphthalene.
Kovalchuk N; Kelty J; Li L; Hartog M; Zhang QY; Edwards P; Van Winkle L; Ding X
Toxicol Appl Pharmacol; 2017 Aug; 329():1-8. PubMed ID: 28527914
[TBL] [Abstract][Full Text] [Related]
36. Rational evolution of the cofactor-binding site of cytochrome P450 reductase yields variants with increased activity towards specific cytochrome P450 enzymes.
Strohmaier SJ; Huang W; Baek JM; Hunter DJB; Gillam EMJ
FEBS J; 2019 Nov; 286(22):4473-4493. PubMed ID: 31276316
[TBL] [Abstract][Full Text] [Related]
37. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
[TBL] [Abstract][Full Text] [Related]
38. Mice deficient in intestinal epithelium cytochrome P450 reductase are prone to acute toxin-induced mucosal damage.
Ahlawat S; Xie F; Zhu Y; D'Hondt R; Ding X; Zhang QY; Mantis NJ
Sci Rep; 2014 Jul; 4():5551. PubMed ID: 24989705
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
[TBL] [Abstract][Full Text] [Related]
40. Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse.
Zhu Y; D'Agostino J; Zhang QY
Drug Metab Dispos; 2011 Jun; 39(6):939-43. PubMed ID: 21349922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
